APOE and Alzheimer disease: Studies such as (Oveisgharan et al., 2018; Gharbi-Meliani et al., 2021) have associated APOE ε4+ phenotype with MCI/AD and its pathology, as well as accelerated cognitive decline in APOE4 carriers compared to non-carriers (Polsinelli et al., 2023).